PharmaTher Holdings Ltd. (OTC:PHRRF – Get Free Report) shares were down 3.1% on Tuesday . The company traded as low as $0.16 and last traded at $0.16. Approximately 200,335 shares changed hands during trading, an increase of 15% from the average daily volume of 174,694 shares. The stock had previously closed at $0.16.
PharmaTher Trading Down 3.1%
The stock has a fifty day moving average price of $0.15 and a two-hundred day moving average price of $0.15.
PharmaTher Company Profile
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury.
Featured Articles
- Five stocks we like better than PharmaTher
- How to Invest in Blue Chip Stocks
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- How to find penny stocks to invest and trade
- Why Boeing May Be Ready to Take Off After Latest Developments
- How to Invest in the FAANG Stocks
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
